• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发性胶质肉瘤罕见的骨质乳突侵犯:病例说明

Rare osseous mastoid invasion of secondary gliosarcoma: illustrative case.

作者信息

Porwal Mokshal, Kramer Dallas E, Chidambaram Smrithi, Chang Jade, Gyure Kymberly, Chen Douglas, Yu Alexander

机构信息

Department of Neurosurgery, Allegheny Health Network, Pittsburgh, Pennsylvania.

Department of Otolaryngology, Allegheny Health Network, Pittsburgh, Pennsylvania.

出版信息

J Neurosurg Case Lessons. 2025 Jul 21;10(3). doi: 10.3171/CASE25179.

DOI:10.3171/CASE25179
PMID:40690793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12278953/
Abstract

BACKGROUND

Gliosarcomas are rare isocitratedehydrogenase-wildtype glioblastomas characterized by their glial and sacromatous components. A gliosarcoma is primary if the tumor arose de novo and secondary if the tumor arose from a previous glioblastoma. Here, the authors describe a unique case of a secondary gliosarcoma invading the mastoid and affecting the horizontal segment of the facial nerve.

OBSERVATIONS

A 69-year-old female presented to the emergency department with 2 weeks of right-sided facial weakness. Six years earlier, she had undergone a gross-total resection for a right temporal glioma and was treated with chemoradiotherapy postoperatively. Pathology confirmed isocitrate dehydrogenase-negative, O6-methylguanine-DNAmethyltransferase-methylated glioblastoma. At current presentation, MRI demonstrated a right temporal tumor that invaded the mastoid. After surgical debulking, the tumor was confirmed to be a secondary gliosarcoma. CT of the temporal bone showed significant tegmen destruction and direct invasion of the horizontal segment of the facial nerve.

LESSONS

Facial weakness was a symptom of the secondary glioscarcoma tumor invading the mastoid and affecting the horizontal segment of the facial nerve. To the authors' knowledge, this symptom has not been previously reported and thus adds to the limited knowledge of secondary gliosarcoma presentations. https://thejns.org/doi/10.3171/CASE25179.

摘要

背景

胶质肉瘤是罕见的异柠檬酸脱氢酶野生型胶质母细胞瘤,其特征在于具有胶质和肉瘤成分。如果肿瘤是新发的,则为原发性胶质肉瘤;如果肿瘤由先前的胶质母细胞瘤发展而来,则为继发性胶质肉瘤。在此,作者描述了一例独特的继发性胶质肉瘤病例,该肿瘤侵犯乳突并影响面神经水平段。

观察结果

一名69岁女性因右侧面部无力2周就诊于急诊科。六年前,她因右侧颞叶胶质瘤接受了全切手术,并在术后接受了放化疗。病理证实为异柠檬酸脱氢酶阴性、O6-甲基鸟嘌呤-DNA甲基转移酶甲基化的胶质母细胞瘤。此次就诊时,MRI显示右侧颞叶肿瘤侵犯乳突。手术减瘤后,肿瘤被证实为继发性胶质肉瘤。颞骨CT显示鼓室盖明显破坏,面神经水平段直接受侵。

经验教训

面部无力是继发性胶质肉瘤侵犯乳突并影响面神经水平段的症状。据作者所知,该症状此前尚未见报道,因此增加了对继发性胶质肉瘤临床表现的有限认识。https://thejns.org/doi/10.3171/CASE25179

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/4e80bab68409/CASE25179_figure_5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/8304c9a4ec30/CASE25179_figure_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/8b6a4ad6dea4/CASE25179_figure_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/5c9d32283c73/CASE25179_figure_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/4f49e422ba89/CASE25179_figure_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/4e80bab68409/CASE25179_figure_5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/8304c9a4ec30/CASE25179_figure_1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/8b6a4ad6dea4/CASE25179_figure_2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/5c9d32283c73/CASE25179_figure_3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/4f49e422ba89/CASE25179_figure_4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58ca/12278953/4e80bab68409/CASE25179_figure_5.jpg

相似文献

1
Rare osseous mastoid invasion of secondary gliosarcoma: illustrative case.继发性胶质肉瘤罕见的骨质乳突侵犯:病例说明
J Neurosurg Case Lessons. 2025 Jul 21;10(3). doi: 10.3171/CASE25179.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Primary versus secondary gliosarcoma: a systematic review and meta-analysis.原发性与继发性胶质肉瘤:系统评价和荟萃分析。
J Neurooncol. 2022 Aug;159(1):195-200. doi: 10.1007/s11060-022-04057-w. Epub 2022 Jun 29.
4
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
5
Surgery for epilepsy.癫痫手术
Cochrane Database Syst Rev. 2015 Jul 1(7):CD010541. doi: 10.1002/14651858.CD010541.pub2.
6
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
7
Composite Reconstruction With Irradiated Autograft Plus Total Hip Replacement After Type II Pelvic Resections for Tumors Is Feasible but Fraught With Complications.肿瘤Ⅱ型骨盆切除术后采用同种异体骨移植加全髋关节置换术进行复合重建是可行的,但并发症多。
Clin Orthop Relat Res. 2024 Oct 1;482(10):1825-1835. doi: 10.1097/CORR.0000000000003097. Epub 2024 Apr 26.
8
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Systemic antibiotics for chronic suppurative otitis media.慢性化脓性中耳炎的全身抗生素治疗。
Cochrane Database Syst Rev. 2021 Feb 4;2(2):CD013052. doi: 10.1002/14651858.CD013052.pub2.

本文引用的文献

1
Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.IDH 野生型胶质母细胞瘤向具有骨肉瘤特征的恶性纤维组织细胞瘤的转化。
Folia Neuropathol. 2024;62(1):96-101. doi: 10.5114/fn.2024.136020.
2
TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma.转化生长因子-β(TGF-β)和骨形态发生蛋白(BMP)信号传导与胶质母细胞瘤向胶质肉瘤进而向骨肉瘤的转变有关。
Neurooncol Adv. 2023 Dec 19;6(1):vdad164. doi: 10.1093/noajnl/vdad164. eCollection 2024 Jan-Dec.
3
Gliosarcoma Invading the Temporal Bone, Temporalis Muscle, and Skull Base.
胶质肉瘤侵犯颞骨、颞肌和颅底。
Cureus. 2023 Jul 23;15(7):e42319. doi: 10.7759/cureus.42319. eCollection 2023 Jul.
4
Metastatic secondary gliosarcoma: patient series.转移性继发性胶质肉瘤:病例系列
J Neurosurg Case Lessons. 2023 May 22;5(21). doi: 10.3171/CASE232.
5
Primary versus secondary gliosarcoma: a systematic review and meta-analysis.原发性与继发性胶质肉瘤:系统评价和荟萃分析。
J Neurooncol. 2022 Aug;159(1):195-200. doi: 10.1007/s11060-022-04057-w. Epub 2022 Jun 29.
6
Gliosarcoma with osteosarcomatous component: A case report and short review illustration.伴骨样肉瘤分化的胶质肉瘤:一例报告及文献复习简述。
Pathol Res Pract. 2022 Apr;232:153837. doi: 10.1016/j.prp.2022.153837. Epub 2022 Mar 7.
7
Clinical and survival characteristics of primary and secondary gliosarcoma patients.原发性和继发性胶质肉瘤患者的临床及生存特征
Clin Neurol Neurosurg. 2022 Mar;214:107146. doi: 10.1016/j.clineuro.2022.107146. Epub 2022 Jan 29.
8
Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.胶质肉瘤的临床特征及相对于传统胶质母细胞瘤的标准化治疗结果
Front Oncol. 2019 Dec 17;9:1425. doi: 10.3389/fonc.2019.01425. eCollection 2019.
9
Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature.胶质肉瘤由PI3K/Akt、RAS/MAPK信号通路改变驱动,并以胶原蛋白基因表达特征为特点。
Cancers (Basel). 2019 Feb 27;11(3):284. doi: 10.3390/cancers11030284.
10
High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.TP53突变的高发生率与胶质肉瘤患者的低生存率及上皮-间质转化特征相关。
Exp Mol Med. 2017 Apr 14;49(4):e317. doi: 10.1038/emm.2017.9.